ZA958229B - Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor - Google Patents

Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor

Info

Publication number
ZA958229B
ZA958229B ZA958229A ZA958229A ZA958229B ZA 958229 B ZA958229 B ZA 958229B ZA 958229 A ZA958229 A ZA 958229A ZA 958229 A ZA958229 A ZA 958229A ZA 958229 B ZA958229 B ZA 958229B
Authority
ZA
South Africa
Prior art keywords
tumor rejection
prcursors
adjuvant
growth factor
composition containing
Prior art date
Application number
ZA958229A
Other languages
English (en)
Inventor
Pierre Van Der Bruggen
Thierry Boon-Falleur
Benoit Van Den Eynde
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of ZA958229B publication Critical patent/ZA958229B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001178—Tumor rejection antigen precursor [TRAP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001186—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA958229A 1994-09-30 1995-09-29 Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor ZA958229B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31596194A 1994-09-30 1994-09-30

Publications (1)

Publication Number Publication Date
ZA958229B true ZA958229B (en) 1996-04-24

Family

ID=23226857

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958229A ZA958229B (en) 1994-09-30 1995-09-29 Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor

Country Status (7)

Country Link
EP (1) EP0782453A1 (fr)
JP (1) JPH10511639A (fr)
CN (1) CN1159759A (fr)
AU (1) AU690371B2 (fr)
CA (1) CA2201327A1 (fr)
WO (1) WO1996010413A1 (fr)
ZA (1) ZA958229B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6328971B1 (en) * 1993-01-22 2001-12-11 Ludwig Institute For Cancer Research MAGE-1 derived nona peptides, and compositions thereof
US5997870A (en) * 1994-06-03 1999-12-07 Ludwig Institute For Cancer Research Isolated peptides which bind to HLA-B44 Molecules
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
JP2001516009A (ja) * 1997-07-17 2001-09-25 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ ガン関連核酸及びポリペプチド
CZ298347B6 (cs) 1998-02-05 2007-09-05 Glaxosmithkline Biologicals S.A. Fúzní protein z rodiny MAGE, kódová sekvence nukleové kyseliny, vektor, hostitelská bunka, vakcina a použití fúzního proteinu pro výrobu vakciny
US6686147B1 (en) 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
GB9826143D0 (en) * 1998-11-27 1999-01-20 Ludwig Inst Cancer Res Tumour rejection antigens
US6809179B1 (en) 1999-08-04 2004-10-26 Boehringer Ingelheim International Gmbh Tumor-associated antigen (R11)
JP2010502310A (ja) 2006-08-30 2010-01-28 ディヴィッド・ウィリアム・スミス 押出成形された材料に単軸又は多軸方向の剛性を付与する方法及び同方法により得られる製品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5405940A (en) * 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
US5462871A (en) * 1992-08-31 1995-10-31 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode MAGE derived nonapeptides

Also Published As

Publication number Publication date
WO1996010413A1 (fr) 1996-04-11
JPH10511639A (ja) 1998-11-10
AU690371B2 (en) 1998-04-23
AU3886495A (en) 1996-04-26
EP0782453A1 (fr) 1997-07-09
CA2201327A1 (fr) 1996-04-11
CN1159759A (zh) 1997-09-17

Similar Documents

Publication Publication Date Title
HUT66753A (en) Novel antibodies and methods for their use
EP0831880A4 (fr) Anticorps et fragments d'anticorps inhibant la croissance des tumeurs
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
IL105848A0 (en) Supports having azlactone-functional surfaces,adduct supports prepared therefrom and the methods of preparing both
ZA958229B (en) Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor
IL85955A0 (en) Human tumor-associated antigen
AU9053991A (en) Conjugates of anti-idiotype antibodies and carriers and their use in epitope-directed immunization
EP0587777A4 (fr) Proteines de liaison d'antigene carcinoembryonnaire et leurs procedes d'isolation et d'utilisation.
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
AU2247095A (en) Cellular immune response-specific antigens and uses therefor
ZA924068B (en) Monoclonal antibodies and antigen for human melanoma
AU4910893A (en) Method for the simultaneous determination of antigens and antibodies
AU9143991A (en) Monoclonal antibody op-g2 and method of use
ZA945696B (en) Novel Eimeria antibodies and antigens and methods of using the same
AU1135595A (en) Saccharomyces-specific antigens and antibodies, their preparation and use
GB9014652D0 (en) Antigen
GB8830115D0 (en) Monoclonal antibody and preparation and use thereof
ZA923759B (en) Tumor rejection antigen precursors,tumor rejection antigens and uses thereof
IL94304A0 (en) Novel tumor-associated antigen,antibodies,compositions and uses therefor
GB2238959B (en) Antigen and conjugates thereof for suppressing immune response
GB9021286D0 (en) Antigens and antibodies thereto their uses
IL104291A0 (en) Antigenic epitopes and antibodies against them
AU2971692A (en) Flystrike antigen and vaccine and method for preparation
IL104767A0 (en) Antigenic epitopes and antibodies against them
NZ242875A (en) Tumour rejection antigens (tra's); tumour rejection antigen precursors (trap's); their uses and properties